of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
Ralph A. DeFronzo(The University of Texas at San Antonio Health Science Center), Steven C. Griffen(Io Therapeutics (United States)), Sreeneeranj Kasichayanula(Gilead Sciences (United States)), Marcus Hompesch(AmeriCorps), Ying Hong(Nanjing Tech University), David W. Boulton(AstraZeneca (Poland)), Marc Pfister(University Children’s Hospital Basel), Linda Morrow(AmeriCorps), Frank LaCreta(Fox Chase Cancer Center), Bruce R. Leslie(Bristol-Myers Squibb (Germany)), Agatha Ching(Bristol-Myers Squibb (Germany)), Xiaoni Liu(Hohai University)
Unknown
January 1, 2013
Cited by 0
Related Papers
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
|Diabetes|2009|3k
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
|Diabetes Care|2009|2.1k
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
|Journal of Clinical Investigation|2009|1.7k
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.
|Journal of Clinical Investigation|1985|1.2k
Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State
|The Journal of Clinical Endocrinology & Metabolism|2007|373